Document is current
Any future updates will be listed below
-
Authors
Niglas, Marili
Whitcher, Brandon
Amiras, Dimitri
Thanaj, Marjola
Basty, Nicolas
Bell-Bradford, Camilo
Thomas, E Louise
Bell, Jimmy D
-
Funding
Funding for this research was provided by:
Calico Life Sciences
- License Information
-
More Information
Article History
Received: 10 November 2025
Revised: 8 July 2026
Accepted: 27 July 2026
First Online: 17 August 2026
Declarations
Conflict of interest: D.A. - Shareholder MedicaliSight Ltd. B.W. - Shareholder Regeneron, Shareholder Hyperfine.
